Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011127570> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2011127570 endingPage "651" @default.
- W2011127570 startingPage "647" @default.
- W2011127570 abstract "Rivaroxaban is an oral direct factor Xa inhibitor that is noninferior to warfarin in the prevention of recurrent venous thromboembolism (VTE). Whether rivaroxaban is cost-effective in the prevention of recurrent VTE, however, is not known.To assess the cost effectiveness of rivaroxaban compared with warfarin in the prevention of recurrent VTE, we built a Markov state-transition model over a 10-year time horizon. The base case analysis consisted of a hypothetical cohort of 60-year-old patients with an initial VTE who received secondary prophylaxis with either rivaroxaban or warfarin for 3 to 12months. Cost estimates were derived from the Healthcare and Utilization Project and other sources. Probabilities were based on literature values. Outcomes included costs in 2011 United States dollars, quality-adjusted life-years (QALYs), and incremental cost effectiveness ratios (ICERs) over 10years from a societal perspective.Compared with warfarin, the rivaroxaban strategy cost less ($3,195 vs. $6,188) and was more effective (9.29 QALYs vs 9.14 QALYs). Our results were highly robust in sensitivity analyses. Warfarin was no longer dominated by rivaroxaban when the risk of major bleeding with rivaroxaban exceeds 3.8% (base case estimate: 0.96%).In summary, prophylactic anticoagulation with rivaroxaban appears to be a cost effective, and perhaps cost saving, alternative to warfarin for the prevention of recurrent VTE." @default.
- W2011127570 created "2016-06-24" @default.
- W2011127570 creator A5008746123 @default.
- W2011127570 creator A5019518672 @default.
- W2011127570 creator A5055393662 @default.
- W2011127570 date "2013-12-01" @default.
- W2011127570 modified "2023-09-27" @default.
- W2011127570 title "Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A U.S. perspective" @default.
- W2011127570 cites W1964644585 @default.
- W2011127570 cites W2011000634 @default.
- W2011127570 cites W2052808930 @default.
- W2011127570 cites W2067741035 @default.
- W2011127570 cites W2097854437 @default.
- W2011127570 cites W2098593309 @default.
- W2011127570 cites W2112275236 @default.
- W2011127570 cites W2115787552 @default.
- W2011127570 cites W2130199362 @default.
- W2011127570 cites W2134047636 @default.
- W2011127570 cites W2171819381 @default.
- W2011127570 cites W2899892054 @default.
- W2011127570 doi "https://doi.org/10.1016/j.thromres.2013.09.015" @default.
- W2011127570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24139508" @default.
- W2011127570 hasPublicationYear "2013" @default.
- W2011127570 type Work @default.
- W2011127570 sameAs 2011127570 @default.
- W2011127570 citedByCount "35" @default.
- W2011127570 countsByYear W20111275702014 @default.
- W2011127570 countsByYear W20111275702015 @default.
- W2011127570 countsByYear W20111275702016 @default.
- W2011127570 countsByYear W20111275702017 @default.
- W2011127570 countsByYear W20111275702018 @default.
- W2011127570 countsByYear W20111275702019 @default.
- W2011127570 countsByYear W20111275702020 @default.
- W2011127570 countsByYear W20111275702021 @default.
- W2011127570 crossrefType "journal-article" @default.
- W2011127570 hasAuthorship W2011127570A5008746123 @default.
- W2011127570 hasAuthorship W2011127570A5019518672 @default.
- W2011127570 hasAuthorship W2011127570A5055393662 @default.
- W2011127570 hasConcept C112930515 @default.
- W2011127570 hasConcept C126322002 @default.
- W2011127570 hasConcept C177713679 @default.
- W2011127570 hasConcept C2776301958 @default.
- W2011127570 hasConcept C2778661090 @default.
- W2011127570 hasConcept C2779161974 @default.
- W2011127570 hasConcept C2780868729 @default.
- W2011127570 hasConcept C2991741193 @default.
- W2011127570 hasConcept C3019080777 @default.
- W2011127570 hasConcept C515549039 @default.
- W2011127570 hasConcept C64332521 @default.
- W2011127570 hasConcept C71924100 @default.
- W2011127570 hasConcept C72563966 @default.
- W2011127570 hasConceptScore W2011127570C112930515 @default.
- W2011127570 hasConceptScore W2011127570C126322002 @default.
- W2011127570 hasConceptScore W2011127570C177713679 @default.
- W2011127570 hasConceptScore W2011127570C2776301958 @default.
- W2011127570 hasConceptScore W2011127570C2778661090 @default.
- W2011127570 hasConceptScore W2011127570C2779161974 @default.
- W2011127570 hasConceptScore W2011127570C2780868729 @default.
- W2011127570 hasConceptScore W2011127570C2991741193 @default.
- W2011127570 hasConceptScore W2011127570C3019080777 @default.
- W2011127570 hasConceptScore W2011127570C515549039 @default.
- W2011127570 hasConceptScore W2011127570C64332521 @default.
- W2011127570 hasConceptScore W2011127570C71924100 @default.
- W2011127570 hasConceptScore W2011127570C72563966 @default.
- W2011127570 hasIssue "6" @default.
- W2011127570 hasLocation W20111275701 @default.
- W2011127570 hasLocation W20111275702 @default.
- W2011127570 hasOpenAccess W2011127570 @default.
- W2011127570 hasPrimaryLocation W20111275701 @default.
- W2011127570 hasRelatedWork W2011127570 @default.
- W2011127570 hasRelatedWork W2070372188 @default.
- W2011127570 hasRelatedWork W2540098030 @default.
- W2011127570 hasRelatedWork W2589914537 @default.
- W2011127570 hasRelatedWork W2901703070 @default.
- W2011127570 hasRelatedWork W3120792855 @default.
- W2011127570 hasRelatedWork W3122483296 @default.
- W2011127570 hasRelatedWork W4242988050 @default.
- W2011127570 hasRelatedWork W4245594149 @default.
- W2011127570 hasRelatedWork W4251340379 @default.
- W2011127570 hasVolume "132" @default.
- W2011127570 isParatext "false" @default.
- W2011127570 isRetracted "false" @default.
- W2011127570 magId "2011127570" @default.
- W2011127570 workType "article" @default.